ASPN Annual Conference 2021

Third Annual

ASPN Conference

Live & In-Person!

July 22-25, 2021
Loews, Miami Beach

Moderators: Timothy Deer, MD; Dawood Sayed, MD; Erika Petersen, MD, FAANS, FACS

  • Cutting edge updates and discussion on topics in pain and neuroscience
  • Continuing the ASPN innovative debates platform to include lively discussion and debates
  • Access to care and important discussion on policy that affects your practice and your patients
  • In depth discussion on patient safety
  • A focus on treatment outcomes and improving the field

Registration

Members: $350
Non-Members: $450
PA, NP, Office Staff: $150
Fellows/Residents: Free
Live Stream with CME Credits: $300
Live Stream without CME Credit: Free

To register for the conference, please click on the registration button below and complete the form.

Register for Conference

Loews Miami Beach Hotel Sold Out
However, additional rooms are available within walking distance. Please contact course management using the button below for assistance with your room.

Booking Assistance

Open the tabs below for helpful conference information

Open the tabs below for helpful conference information

Instructions
ASPN_App_Flyer_2021
ASPN Annual 5k Charity Race

Join Us For Our 11th Annual

ASPN PAIN 2021 5K Miami Vice Chase Race

Friday, July 23rd, 2021

Annual dynamic charitable event that has benefitted both local, national charities and beneficiaries

Race shirts are available to all thanks to Kelly Castleberry at Morgan Stanley/Graystone

Post race celebration is sponsored by Basic Home Infusion

Morgan StanleyBasic Home Infusion

Race Directors: Timothy Deer, MD, Chris Kim, MD, Kelly Castleberry, Michelle Byers-Robson

Prior Race Beneficiaries: Make-a-Wish, IRONAID, IRONMAN FOUNDATION, CHALLENGED ATHLETES FOUNDATION

This year we will have: Team competition and individual awards for women and men

Registration: $50 per person

Register for Race
Make A Donation
Download
PSPS Annual Conference Agenda
Download
ASPN Pain 2021 Faculty Page
Supported by Abbott, Aurora Spine, Boston Scientific, Captiva Spine, CornerLoc, Medtronic, Nalu Medical, Nevro Corp., PainTEQ, Spinal Simplicity, SPR Therapeutics, Stratus Medical, SurGenTec, Vertos Medical, and VIVEX Biologics.

In Kind Support provided by Clint Pharmaceuticals, ControlRad, and RGS Healthcare.

ACTIVITY DESCRIPTION AND STATEMENT OF NEED

The goal of ASPN PAIN, 2021 is to provide a unique and dynamic program on the most up to date, cutting edge, information on therapies available to treat patients in pain. Each faculty member is a recognized leader in the field. Information and data presented will be on label and present the most recent and relevant information available with a focus on improving patient care, access to therapies, and overall outcomes.

Format will include individual lectures, panel discussions and cases. Implementing courses and hands on workshops will also be available.

TARGET AUDIENCE

This certified CME activity will unite over 1,000 attendees, both in person and virtually from across the United States, Europe and Caribbean including: engineers, researchers, anesthesiologists, neurosurgeons, neurologists, pain medicine specialists, and venture capitalists.

The faculty of nationally known physicians specializing in neuromodulation and pain management will be presenting on topics relevant to the treatment of patients in pain and other disorders.

LEARNING OBJECTIVES

Upon completion of this activity, the participant should be able to:

  1. Recognize and evaluate pain, description of pain, and pain markers.
  2. Interpret new Federal Regulations to assist in implementing standards of care and to assist in patient and compliance.
  3. Discuss established and evolving concepts in interventional pain management.
  4. Achieve a greater understanding of best practices and available guidelines on new techniques, agents and therapies for patients.

ACCREDITATION STATEMENT

Jointly Provided by Evolve Medical Education, LLC and Mantra Meetings.
Evolve and Mantra Meetings

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC; Mantra Meetings; and the American Society of Pain & Neuroscience (ASPN). Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians

Evolve Medical Education designates this live activity for a maximum of 25.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Evolve Medical Education, LLC is an approved provider by the California Board of Registered Nursing, Provider Number 17004 for 25.5 contact hours.

TO OBTAIN CREDIT

To obtain credit for this activity, you must complete the activity in its entirety; register or log onto Evolve Medical Education website: https://evolvemeded.com and complete the Activity Evaluation/Satisfaction Measures Form at https://evolvemeded.com/course/ASPN-PAIN2021.

Upon completing the activity and self-assessment test, you may print a CME certificate. Credit is provided through August 25, 2021.

In the event you have questions about this activity or are unable to retrieve the certificate, please email info@evolvemeded.com.

DISCLOSURE POLICY

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

  • Alaa Abd-Elsayed, MD, MPH, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Avanos (Active); Grant/Research Support: Medtronic.
  • Kasra Amirdelfan, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Grant/Research Support: Nevro, Medtronic, Biotronik, Boston Scientific, Nalu, Vivex; Consultant: Nevro, Medtronic, Biotronik, Boston Scientific, Nalu, Vivex; Shareholder: Nalu; Other Financial/Material Support: Hourly consulting for Nevro, Medtronic, Biotronik, Boston Scientific, Nalu, Vivex.
  • Dave Anderson, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Medtronic; Employee: Medtronic.
  • Ajay Antony, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, PainTEQ; Grant/Research Support: Abbott, Boston Scientific, Nalu, PainTEQ, SPR Therapeutics.
  • Miguel D. Attias, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Captiva Spine.
  • Nomen Azeem, MD, FAAPMR has no financial relationships to disclose.
  • Javid M. Baksh, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Abbott, Flowonix.
  • Douglas P. Beall, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Spineology, Merit Medical, Johnson & Johnson, IZI, Techlamed, Peterson Enterprises, Medical Metrics, Radius Pharmaceuticals, Avanos, Boston Scientific, Sollis Pharmaceuticals; Grant/Research Support: Medtronic, Medical Metrics, Avanos, Relievant, Boston Scientific, Stryker, Sollis Pharmaceuticals, Simplify Medical, Lenoss Medical, Spine BioPharma, Eliem Therapeutics, Smart Soft, Tissue; Speaker’s Bureau: Radius Pharmaceuticals, Stryker, Medtronic, Boston Scientific, Merit, Avanos, Piramal, Genesys, elliquence; Shareholder: Artio, Sophiris, Eleven Biotherapeutics, Radius Pharmaceuticals, Flow Forward, Lenoss Medical, Spine BioPharma, ReGelTech, Spark Biomedical.
  • Marshall Bedder, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Boston Scientific.
  • Helen M. Blake, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott.
  • Keith Boettiger, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: President, Abbott Neuromodulation.
  • Christopher Bovinet, DO, FAAPMR, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro, Boston Scientfic (Vertiflex), PainTEQ.
  • Patrick Buchanan, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, PainTEQ, Aurora Spine; Grant/Research Support: Abbott, PainTEQ.
  • Anjum Bux, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Flowonix, Boston Scientific; Grant/Research Support: Flowonix; Speaker’s Bureau: Flowonix, Boston Scientific, Vertos Medical; Shareholder: Boston Scientific.
  • Kevin Cairns, MD, MPH, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Boston Scientific.
  • Aaron K. Calodney, MD, FASA, FIPP, ABIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Stryker, Nevro; Grant/Research Support: Medtronic, Boston Scientific.
  • David Caraway, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: Chief Medical Officer, Nevro Corp.
  • Alexios Carayannopoulos, DO, MPH, DABPMR, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Pain Spine and Rehabilitation Consulting; Grant/Research Support: Mainstay Medical, Nevro Corp., DARPA, Aspen Medical.
  • Kelly L. Castleberry, III, CIMA®, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: Senior Vice President, Financial Advisor, Family Wealth Advisor, Graystone Consulting.
  • Jonathan D. Carlson, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Saluda Medical, Boston Scientific, CornerLoc, Mainstay Medical, Biotronik; Grant/Research Support: Abbott, Biotronik, Saluda, Mainstay Medical; Speaker’s Bureau: Abbott, Saluda Medical, Boston Scientific, CornerLoc, Mainstay Medical, Biotronik; Shareholder: Mainstay Medical, CornerLoc.
  • Krishnan Chakravarthy, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Vivex Biologics, Medincell, Bioness, PainTEQ; Shareholder: Aya Bioscience, Higgs Boson Health, Mainstay Medical, Nalu Medical, Oska Wellness, UMEHEAL.
  • Kenneth B. Chapman, MD, has no financial relationships to disclose.
  • Mark H. Coleman, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Abbott, Aurora Spine.
  • Ashley G. Comer, APRN, NP-C, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Saluda Medical, Vertos Medical, SPR Therapeutics, PainTEQ.
  • Bob Compton, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Founder and Manager, CornerLoc
  • Harold Cordner, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic.
  • Alane B. Costanzo, MD, has no financial relationships to disclose.
  • Tammy Dann, DO, MPH, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Spouse: FH Ortho; Speaker’s List: Medtronic.
  • Timothy T. Davis, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Biostar, Kolon Tissuegene, Nevro, Paradigm Spine (RTI), Tenex Health; Grant/Research Support: Abbott, Biostar, Discgenics, Kolon Tissuegene, Mesoblast, Nevro, Boston Scientific, VIVEX Biologics; Speaker’s Bureau: Abbott, Boston Scientific; Advisory Board: Abbott, Biostar, Discgenics, Forever Labs, Galant, Kolon Tissuegene, PeteHealth, Boston Scientific; Shareholder: Alpha Diagnostics, ATAI Life Sciences, Beckley Psytech, Broadway Surgical Institute, Bryn Pharma, Compass Pathways, Dama, Eaze, Flowhub, Forever Labs, Galant, Kiva, PeteHealth, Leaflink, Paradigm Spine (RTI), Prosidyan, Source Healthcare, Source Surgery Center, Source Practice Solutions IP Holdings, Spine Biopharma, Tenex Health.
  • Miles Day, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Alethiah.
  • Timothy R. Deer, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Vertos Medical, Flowonix, Axonics, SpineThera, Saluda, Nalu, CornerLoc, SPR Therapeutics, Stimgenics, SI-BONE, Nevro, Medtronic, Boston Scientific, PainTEQ; Grant/Research Support: Abbott, Vertos, Saluda Medical, Mainstay, SPR Therapeutics, Boston Scientific; Shareholder: Options Only: Vertos Medical, Axonics, SpineThera, Saluda, Nalu, CornerLoc, SPR Therapeutics, PainTEQ.
  • Didier Demesmin, MD, MBA, DABA, has no financial relationships to disclose.
  • Myrdalis Díaz-Ramírez, MD, has no financial relationships to disclose.
  • David Dickerson, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, SPR Therapeutics, Vertos Medical; Grant/Research Support: Abbott; Speaker’s Bureau: Abbott, SPR Therapeutics, Vertos Medical; Shareholder: Anesthesia & Pain Care Services (S Corp), sole employee.
  • Sudhir Diwan, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Apex Biologix; Shareholder: CornerLoc.
  • Michael Dorsi, MD, has no financial relationships to disclose.
  • Shravani Durbhakula, MD, has no financial relationships to disclose.
  • Michael Enxing, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: Chief Commercial Officer at Boston Scientific Neuromodulation Division (Vertiflex).
  • Alexander Escobar, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Medtronic, Nevro Corp., Vertos Medical.
  • Yashar Eshraghi, MD, has no financial relationships to disclose.
  • Michael F. Esposito, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Medtronic, Nevro; Grant/Research Support: Abbott, Boston Scientific, Medtronic, Nevro, CornerLoc; Speaker’s Bureau: Abbott, Boston Scientific, Medtronic, Nevro.
  • Steven M. Falowski, MD, FAANS, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Medtronic, Boston Scientific, Vertos Medical, Saluda Medical, CornerLoc; Grant/Research Support: Medtronic, Abbott, Nalu, Boston Scientific, Saluda Medical, Boston Scientific; Speaker’s Bureau: Abbott, Medtronic, Boston Scientific; Shareholder: Saluda Medical, CornerLoc, PainTEQ, Aurora Spine, Thermaquil, SPR Therapeutics, SpineThera, Celeri Health.
  • Michael A. Fishman, MD, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Aurora Pain Care, Biotronik, Camber Spine, Medtronic, and Thermaquil; Grant/Research Support: Abbott, Biotronik, InterAxon, Lumbrera, Medtronic, Nalu Medical, Saluda Medical, Stimgenics, Thermaquil, Vertiflex; Speaker’s Bureau: Abbott, Aurora Spine, IMSE, Medtronic; Shareholder: Celeri Health, Thermaquil.
  • Vincent Galan, MD, MBA, DABPM, has no financial relationships to disclose.
  • Michael J. Gesquiere, MD, has no financial relationships to disclose.
  • Priyanka Ghosh, MD, has no financial relationships to disclose.
  • George E. Girardi, MD, has no financial relationships to disclose.
  • Anthony T. Giuffrida, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Relievant, BioTras, ControlRad, Immertec; Speaker’s Bureau: Relievant, BioTras, ControlRad, Immertec.
  • Brian J. Goentzel, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Relievant, Abbott; Speaker’s Bureau: Vertos Medical.
  • Stanley Golovac, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Vivex, Saluda Medical, Abbott; Speaker’s Bureau: Vertos Medical, Vivex, Saluda Medical, Abbott.
  • Johnathan H. Goree, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Stratus Medical; Grant/Research Support: SPR Therapeutics.
  • Travis Greenhalgh, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Founder and CEO: SurGenTec.
  • Prabhdeep K. Grewal, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic; Grant/Research Support: Stimgenics, Medtronic; Speaker’s List: Medtronic.
  • Jay S. Grider, DO, PhD, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Other Financial/Material Support: Intralink Spine.
  • Casey Grillo, FNP-C, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott.
  • Maged Guirguis, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro, Saluda Medical, SPR Therapeutics, Avanos; Grant/Research Support: Nevro, Abbott, Saluda Medical, Nalu Medical and Avanos.
  • Amitabh Gulati, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, AIS HealthCare, Flowonix, Spark Medical, SPR Therapeutics, Nalu Medical.
  • Mayank Gupta, MD, has no financial relationships to disclose.
  • Jonathan M. Hagedorn, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Nevro Corp.
  • Jennifer Hah, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nalu Medical.
  • Jason Hannon, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: Chief Executive Officer, Mainstay Medical.
  • Robert D. Heros, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Biotronik, Boston Scientific; Grant/Research Support: Abbott, Mainstay Medical, Nevro, Saluda Medical; Speaker’s Bureau: Boston Scientific.
  • Michael Hoffmann, MD, PhD, has no financial relationships to disclose.
  • Corey W. Hunter, MD, FIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Saluda Medical; Grant/Research Support: Abbott, Saluda Medical, Biotronik, Mesoblast, Discgenics, VIVEX Biologics; Shareholder: Nalu, Mainstay, Spine Biopharma, PainTEQ, VIVEX Biologics.
  • Zohra Hussaini MSN, FNP-BC, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro, Averitas, Vertos Medical; Speaker’s Bureau: Flowonix.
  • Sameer Jain, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Omnia; Grant/Research Support: Flowonix; Speaker’s Bureau: Flowonix.
  • Jessica Jameson, MD, FASA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Nevro Corp., PainTEQ.
  • Navdeep S. Jassal, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Flowonix, Abbott, Boston Scientific, Medtronic, CornerLoc; Grant/Research Support: Flowonix, Vertos Medical; Speaker’s Bureau: Vertos Medical, Flowonix, Abbott, Medtronic, CornerLoc.
  • Youssef Josephson, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: PainTEQ, Abbott; Speaker’s Bureau: Medtronic, Boston Scientific, Abbott, SNAP, Bioness.
  • Hemant Kalia, MD, MPH, has no financial relationships to disclose.
  • Leonardo Kapural, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Abbott, Avanos; Grant/Research Support: Medtronic, Abbott, Avanos.
  • Christopher K. Kim, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Vertos Medical, PainTEQ; Shareholder: PainTEQ.
  • Ankur Khosla, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Spinal Simplicity.
  • Nebojsa Nick Knezevic, MD, PhD, has no financial relationships to disclose.
  • Lisa R. Kroopf, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Boston Scientific, Abbott Laboratories.
  • Sean LaNeve, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: PainTEQ (CEO).
  • David W. Lee, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Abbott Neuromodulation.
  • Eric T. Lee, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Nalu; Grant/Research Support: Saluda Medical.
  • Jennifer M. Lee, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Boston Scientific, Surgalign; Grant/Research Support: Boston Scientific; Speaker’s Bureau: Boston Scientific.
  • Michael S. Leong, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Sorrento Therapeutics; Grant/Research Support: Wex Pharmaceuticals.
  • Robert M. Levy, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Stock options from Nalu and Saluda Medical obtained prior to 2019, and not exercisable through the duration as my term as INS President, and Editor-in-Chief of the journal, Neuromodulation Technology at the Neural Interface.
  • Sean Li, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Avanos, Biotronik, Boston Scientific, Nalu, Nevro Corp., PainTEQ, Saluda Medical, SI-BONE, SPR Therapeutics, Vertos Medical; Grant/Research Support: Avanos, Biotronik, Boston Scientific, Nevro Corp., Saluda Medical, SGX Medical, SPR Therapeutics; Speaker’s Bureau: Gruenthal Pharmaceuticals; Shareholder: Nalu, National Spine and Pain Centers.
  • Timothy R. Lubenow, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott Labs, Nevro Corp.
  • Mark N. Malinowski, DO, FIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott Laboratories, Nalu Medical LLC, SI-BONE Inc.; Grant/Research Support: Abbott Laboratories; Speaker’s Bureau: Abbott Laboratories, Nalu Medical LLC, SI-BONE Inc.; Shareholder: PrescribeFIT Strategic Investors LLC.
  • Juan-Pablo Mas, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: GSK, Saluda Medical, Setpoint Medical, Cala Health, CVRx, Axon Therapies, Neuspera Medical, Presidio Medical, Exo Imaging, Alpheus Medical, CLM, Gradient Denervation Technologies, Reflexion.
  • Tory McJunkin, MD, DABA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Nevro Corp., Omnia.
  • Lauren McLaughlin-Abrams, DO, has no financial relationships to disclose.
  • Kathleen W. Meacham, MD, PhD, has no financial relationships to disclose.
  • Neel Mehta, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro Corp., Salix; Grant/Research Support: Nevro Corp.
  • Pankaj Mehta, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Boston Scientific, Abbott, CornerLoc, PainTEQ, Ethos Laboratories, Spinal Simplicity, Aurora Spine, SPR Therapeutics; Speaker’s Bureau: Boston Scientific, Abbott, CornerLoc, PainTEQ, Ethos Laboratories, Spinal Simplicity, Aurora Spine, SPR Therapeutics.
  • Nagy Mekhail, MD, PhD, has no financial relationships to disclose.
  • John S. Michels, MD, has no financial relationships to disclose.
  • Brittney Misercola, MSN, APRN, FNP-C, CFRN, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, SPR Therapeutics; Grant/Research Support: Abbott, Boston Scientific, SPR Therapeutics; Speaker’s Bureau: Abbott, Boston Scientific, SPR Therapeutics.
  • Behnam Myers, DO, MPH, has no financial relationships to disclose.
  • Ramana K. Naidu, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Avanos, Boston Scientific, CereVu, DoctorPlan, ExerAI, Medtronic, SPR Therapeutics, Nalu, Vertos, KarunaLabs, Relievant, SonoSite, Vivex, Omnia Medical, Bicycle Health; Grant/Research Support: Abbott, Boston Scientific, CereVu, Nalu; Speaker’s Bureau: Avanos, Abbott, Boston Scientific, Relievant, Vivex, Nalu, SPR Therapeutics, SonoSite; Shareholder: ExerAI, DoctorPlan, CereVu, PainTEQ, KarunaLabs.
  • Maulik Nanavaty, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Rani Therapeutics Board of Directors; Shareholder: President, Boston Scientific Neuromodulation.
  • Yeshvant A. Navalgund, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Abbott, Medtronic, SI-BONE.
  • Dan T. D. Nguyen, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Medtronic.
  • Harold Nijhuis, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Saluda Medical; Grant/Research Support: Abbott.
  • John R. Orphanos, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: SI-BONE; Speaker’s Bureau: SI-BONE.
  • Richard M. Paicius, MD, has no financial relationships to disclose.
  • Anish S. Patel, MD, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro Corp., Medtronic, Abbott, Flowonix, Camber Spine; Shareholder: Aurora Spine, AIS Healthcare.
  • Kiran V. Patel, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific; Speaker’s Bureau: Abbott.
  • Denis G. Patterson, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbot, AIS, Allergan, Amgen, CornerLoc, Flowonix, Lundbeck, Saluda, Spark Biomedical, Vertos Medical; Grant/Research Support: Abbott, Flowonix, Nevro, Saluda Medical; Speaker’s Bureau: Abbott, Allergan, Amgen, CornerLoc, Flowonix, Lundbeck, Vertos Medical; Shareholder: CornerLoc.
  • Erika A. Petersen, MD, FAANS, FACS, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro Corp., Abbott, Medtronic, Vertos Medical; Grant/Research Support: Nevro Corp., Saluda Medical, Neuros Medical, ReNeuron; Shareholder: SynerFuse.
  • Jason E. Pope, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Ethos, Flowonix, Saluda Medical, PainTEQ, Aurora Spine, Thermaquil, Abbott, Medtronic, Vertos Medical, SPARK, SPR Therapeutics, WISE, TerSera Therapeutics; Grant/Research Support: Ethos Labs, Flowonix, Saluda, PainTEQ, Aurora Spine, Thermaquil, Celeri Health, Abbott, Medtronic, AIS, Boston Scientific, Vertos Medical, Spark; Shareholder: PainTEQ, Aurora Spine, Thermaquil, Celeri Health, SpineThera, AGR, NIS, Vertos Medical, Spark.
  • John V. Prunskis, MD, FIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Other Financial/Material Support: Medical Director, DxTx Pain and Spine.
  • Peter G. Pryzbylkowski, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Nevro Corp., Camber Spine.
  • Matthew T. Ranson, MD, has no financial relationships to disclose.
  • Louis J. Raso, MD, PA, has no financial relationships to disclose.
  • Edgar Alfonso Romero-Sandoval, MD, PhD, has no financial relationships to disclose.
  • Jason Rosenberg, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Boston Scientific (Vertiflex), Abbott; Speaker’s Bureau: Vertos Medical, Boston Scientific (Vertiflex), Abbott.
  • David Rosenblum, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: SPR Therapeutics (SPRINT), Bioness, Nalu Medical, Clarius, Pfizer; Shareholder: Clarius Options.
  • Dawood Sayed, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Medtronic, Vertos Medical, PainTEQ; Grant/Research Support: Nevro Corp.; Shareholder: PainTEQ, NeuraLace Medical, Vertos Medical, SPR Therapeutics.
  • Michael E. Schatman, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Firstox; Shareholder: Modoscript.
  • Keith W. Schmidt, MD, has no financial relationships to disclose.
  • S. Matthew Schocket, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott.
  • Jim Schuermann, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: Saluda Medical.
  • Jay M. Shah, MD, FAAPMR, has no financial relationships to disclose.
  • Lindsay N. Shroyer, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker’s Bureau: Vertos Medical.
  • Gurtej Singh, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro Corp., Medtronic, Southern Spine; Grant/Research Support: Nevro Corp., Southern Spine; Speaker’s Bureau: Nevro Corp., Medtronic, Southern Spine.
  • Vinita Singh, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Releviate LLC.
  • Konstantin V. Slavin, MD, FAANS, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic, Abbott, Boston Scientific, Integer, Stimwave; Grant/Research Support: Medtronic, Abbott, Boston Scientific, Neuros; Shareholder: Stimwave, Neuramodics, Thermaquil, Higgs Boston.
  • Amol Soin, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Grant/Research Support: Avanos, Neuronoff, Neuros; Shareholder: Neuros, Neuronoff, Soin Neuroscience.
  • Dawn A. Sparks, DO, has no financial relationships to disclose.
  • Peter S. Staats, MD, MBA, FIPP, ABIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: National Spine & Pain Centers; Shareholder: electroCore, National Spine & Pain Centers, Saluda Medical, SPR Therapeutics; Other Financial/Material Support: electroCore.
  • Chad B. Stephens, DO, has no financial relationships to disclose.
  • Natalie H. Strand, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott-have lectured at 2 webinars; Speaker’s Bureau: Abbott-have lectured at 2 webinars; Shareholder: Boston Scientific, Retirement husband use to work there.
  • Mark Stultz, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Equity Ownership SPR Therapeutics.
  • Harry P. Sukumaran, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Boston Scientific, Nevro Corp., SPR Therapeutics; Grant/Research Support: CornerLoc.
  • Jeanmarie Tari, MSN, CARN, FNP, BC, has no financial relationships to disclose.
  • Jordan Lee Tate, MD, MPH, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro, PainTEQ, Medtronic; Grant/Research Support: Nalu Medical, Nevro, Boston Scientific; Speaker’s Bureau: Nevro, PainTEQ.
  • Nestor D. Tomycz, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott; Grant/Research Support: Abbott, Boston Scientific.
  • Ali Valimahomed, MD, FAAPMR, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: CornerLoc, Vertos Medical (MILD), Guidepoint Consulting; Grant/Research Support: SPR Therapeutics.
  • Ricardo Vallejo, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic; Speaker’s Bureau: Medtronic; Shareholder: SGX-Medical ( No commercial product).
  • Michael Verdolin, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Medtronic, Boston Scientific; Grant/Research Support: Abbott.
  • Jacqueline Weisbein, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Medtronic, Saluda Medical, Vertos Medical, PainTEQ, Boston Scientific; Grant/Research Support: Abbott, Medtronic, Saluda Medical; Speaker’s Bureau: Abbott, Medtronic, Saluda Medical, Vertos Medical, PainTEQ.
  • Eric Wichems, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Other Financial/Material Support: Vertos Medical.
  • Derron K. Wilson, MD, FIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, BIOTRONIK; Grant/Research Support: Abbott, Boston Scientific; Speaker’s Bureau: Abbott, Boston Scientific, BIOTRONIK.

The Evolve staff/planners and Mantra Meetings staff/planners have no financial relationships with commercial interests.

Myrdalis Díaz-Ramírez, MD, Hemant Kalia, MD, MPH, and Christopher M. Lam, MD, peer reviewers, have no relevant financial relationships with commercial interests.

OFF-LABEL STATEMENT

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Mantra Meetings, the American Society of Pain & Neuroscience (ASPN), Abbott, Aurora Spine, Boston Scientific, Captiva Spine, Clint Pharmaceuticals, ControlRad, CornerLoc, Medtronic, Nalu Medical, Nevro Corp., PainTEQ, RGS Healthcare, Spinal Simplicity, SPR Therapeutics, Stratus Medical, SurGenTec, Vertos Medical, or VIVEX Biologics.

Download
ASPN Annual LAB Agenda
Download
ASPN 2021 Exhibit Floor Plan
First of all, the entire staff and I would like to express our sincere appreciation of your company’s support for the upcoming ASPN 2021 Annual Conference! We are thrilled to be working with you in to provide an outstanding educational opportunity for all attendees.

“PAIN, 2021” will take place Friday, July 23 – Sunday, July 25th, 2021 at the Loews Miami Beach Hotel in Miami, FL. There will be an offsite hands-on training course Thursday, July 22nd. All other sessions and events will be taking place onsite at the hotel.

All Platinum, Gold, Silver, Bronze, and Program sponsors are invited to have a table display throughout the conference hours. All exhibitors are invited to attend all medical sessions and events – however, everyone MUST have a badge. Please be sure to let us know who on your team will need badges so we have these prepared and names are spelled correctly.

Please plan on arriving to set up your display on Thursday, July 22nd from 2:00PM – 6:00 PM – you are welcome to leave your materials and tabletop display up for all hours of the conference, and we recommend tear down at the end of the day on Saturday, July 24th.

Download
ASPN Exhibitor Instructions